Neoplasm of Uncertain Histogenesis — Trials

Neoplasm of Uncertain Histogenesis — Trials · CancerIndex

Clinical trials

Registered studies

91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 401–450 of 860 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04128020	Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia	withdrawn	Phase 1	0	Sherif FaragOTHER	0	Oct 12, 2020	clinicaltrials
NCT02786485	Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT	withdrawn	Phase 1	0	Bellicum PharmaceuticalsINDUSTRY	0	Oct 5, 2020	clinicaltrials